1444
K. Smiataczowa et al. / Carbohydrate Research 339 (2004) 1439–1445
0
Germany) in the CCl4–acetone solvent system 3:1 (v/v);
Evaporations were carried out under diminished pres-
sure at 30–40 ꢁC.
J5;6 1.98 Hz, H-60), 6.35–7.83 (H-pyrazole). FDMS: m=z
231 [Mþþ1].
3.2.3. 1-(2,3,4,6-Tetra-O-acetyl-b-
dazole (Ib). A mixture of 1-bromo-2,3,4,6-tetra-O-acet-
yl- -glucopyranose (2.4 g, 6 mmol), imidazole (1 g,
D-glucopyranosyl)imi-
3.2. Reagents
D
MeOH was first dried over Na2SO4 and then magnesium
methoxide and distilled.26 To remove basic impurities,
0.4 g of tartaric acid was added per 1 L of the solvent
and distillation was repeated.27 Finally, the solvent was
distilled through a Widmer column and a fraction
boiling strictly at the bp of pure MeOH, that is 65 ꢁC/
1013 hPa,9 was collected. Dioxane were purified by using
procedures reported in the literature.26
15 mmol), and dioxane (40 mL) was refluxed for 1.5 h.
During the heating imidazole hydrobromide fell out.
The dioxane layer was decanted and the solvent was
distilled off under reduced pressure. The residue was
dissolved in CHCl3. The chloroformic solvent was wa-
shed with dilute ammonia followed by water and dried
over MgSO4. Recrystallization from MeOH gave nee-
21
D
dles (1 g, 41%): mp 210–212 ꢁC; ½a À7.3 (c 1.5,
CHCl3); Rf 0.75; IR m 1738.3, 1280 (C@O ester), 1236.8
1
(C–O–C ether); H NMR (CDCl3): d 5.33 (d, 1H, J1;2
3.2.1. 1-(2,3,4,6-Tetra-O-acetyl-b-
azole (Ia). To a solution of 1-bromo-2,3,4,6-tetra-O-
acetyl-N- -glucopyranose (1.23 g, 3 mmol), and pyraz-
D-glucopyranosyl)pyr-
6.54 Hz, H-1), 5.34 (t, 1H, J2;3 10.8 Hz, H-2), 5.32 (t, 1H,
J3;4 8.6 Hz, H-3), 5.24 (t, 1H, J4;5 10.2 Hz, H-4), 3.93 (m,
D
0
1H, J5;6 4.94 Hz, H-5), 4.28 (dd, 1H, J5;6 2.2 Hz, H-6),
ole (0.23 g, 3.3 mmol) in a mixture nitromethane (17 mL)
and toluene (17 mL) Hg(CN)2 (0.76 g, 3 mmol) was
added. The mixture was stored for 15 h at room tem-
perature. After removal of the solvents under reduced
pressure, the residue was dissolved in chloroform
(200 mL) and filtered. The chloroformic solution was
washed with a 1 M KI solution, water, then dried with
MgSO4, and concentrated. The product was crystallized
4.16 (dd, 1H, J6;6 12.65 Hz, H-60), 2.09, 2.07, 2.02, and
0
1.88 (each 3H, s, OAc), 7.63–7.09 (H-imidazole); 13C
NMR (CDCl3): 83.91 (C-1), 70.80 (C-2), 73.13 (C-3),
68.06 (C-4), 75.15 (C-5), 61.92 (C-6), 116.99–136.87 (C-
imidazole), 20.34–20.89 (OAc), 168.88–170.73 (C@O).
FDMS: m=z 399 [Mþþ1]. Anal. Calcd for C17H22N2O9
(398.36): C, 51.26; H, 5.57; N, 7.03. Found: C, 51.36; H,
5.59; N, 6.83.
from MeOH to give 1-(2,3,4,6-tetra-O-acetyl-b-D-glu-
21
D
copyranosylpyrazole (0.69 g, 58%): mp 136–137 ꢁC; ½a
3.2.4. 1-b-D-Glucopyranosylimidazole (Gli). To a solu-
À6.4 (c 1, CHCl3); Rf 0.36; IR m 1753.8 (C@O), 1229.6
tion of Ib (0.14 g, 0.35 mmol) in abs MeOH (2.4 mL)
Et3N(0.15 mL, 1.09 mmol) was added. The mixture was
stored at room temperature; no 1-(2,3,4,6-tetra-O-acet-
1
(C–O–C), 1318.5 (C–N); H NMR (CDCl3): d 5.56 (d,
1H, J1;2 8.78 Hz, H-1), 5.59 (t, 1H, J2;3 9.02 Hz, H-2),
5.37 (t, 1H, J3;2 9.02 Hz, H-3), 5.26 (t, 1H, J4;3 9.75 Hz,
yl-b-
After evaporation to dryness the product was crystal-
lized from MeOH to give 1-b- -glucopyranosylimidaz-
D-glucopyranosyl)imidazole was detected (TLC).
0
H-4), 3.95 (m, 1H, J5;4 10.11 Hz, H-5), 4.30 (dd, 1H, J6;6
0
12.43 Hz, J5;6 4.39 Hz, H-6), 4.15 (dd, 1H, J5;6 1.95 Hz,
D
21
H-60), 2.08, 2.07, 2.04, and 1.86 (each 3H, s, OAc), 6.35–
7.62 (H-pyrazole); 13C NMR (CDCl3): d 87.30 (C-1),
70.45 (C-2), 73.40 (C-3), 68.16 (C-4), 74.74 (C-5), 61.98
(C-6), 107.55–140.98 (C-pyrazole), 20.42–20.91 (OAc),
169.12–170.80 (C@O). FDMS: m=z 399.3 [Mþþ1]. Anal.
Calcd for C17H22N2O9 (398.36): C, 51.26; H, 5.57; N,
7.03. Found: C, 51.17; H, 5.56; N, 6.08.
ole (57%); mp 216–219 ꢁC, ½a +13.6 (c 1.5, CHCl3),
D
25
½a +12.0 (c 0.46, MeOH); Rf 0; IR (KBr); m 3400 and
546
3200 (OH); 1H NMR (CD3OD): d 5.19 (d, 1H, J1;2
8.79 Hz, H-1), 3.60 (t, 1H, J2;3 9.15 Hz, H-2), 3.49 (t, 1H,
J
3;4 8.42 Hz, H-3), 3.47 (t, 1H, J4;5 10.2 Hz, H-4), 3.51 (m,
0
1H, J5;6 5.13 Hz, H-5), 3.71 (dd, 1H, J5;6 1.83 Hz, H-6),
3.88 (dd, 1H, J6;6 12.07 Hz, H-60), 6.99–7.85 (H-imid-
0
azole); 13C NMR (CDCl3): d 87.67 (C-1), 74.79 (C-2),
78.79 (C-3), 71.20 (C-4), 81.05 (C-5), 62.66 (C-6),
119.20–138.23 (C-imidazole). FDMS m=z 231 [Mþþ1].
Anal. Calcd for C9H14N2O5 (230.22): C, 46.95; H, 6.13;
N, 12.16. Found: C, 46.83; H, 6.44; N, 11.92.
3.2.2. 1-b-D-Glucopyranosylpyrazole (Glp). To a solution
of Ia (0.217 g, 0.55 mmol) in abs MeOH (2.4 mL) Et3N
(0.15 mL, 1.09 mmol) was added. The mixture was
stored at room temperature; no 1-(2,3,4,6-tetra-O-acet-
yl-b-
After evaporation to dryness the product was crystal-
lized from MeOH to give 1-b- -glucopyranosylpyrazole
D-glucopyranosyl)pyrazole was detected (TLC).
3.2.5. N-(m-Nitrophenyl)-b-D-glucopyranosylamine (Gln).
D
This was synthesized by refluxing a solution of 5.4 g
(27 mmol) of glucose p.a. and 4.5 g (30 mmol) of previ-
ously steam-distilled m-nitroaniline in 40 mL of
MeOH.11 On the next day, the precipitate was washed
with diethyl ether, dried, and recrystallized from ca.
50 mL of 96% ethanol p.a. After drying in an open
vessel, its mp was 173–175 ꢁC and the initial specific
21
25
(85.7%): mp 216–219 ꢁC; ½a +3.18 (c 1, MeOH), ½a
D
546
+6.0 (c 0.46, MeOH); Rf 0; IR m 3400 and 3200 (OH); 1H
NMR (CD3OD): d 5.26 (d, 1H, J1;2 9.12 Hz, H-1), 3.90
(t, 1H, J2;3 8.73 Hz, H-2), 3.47 (t, 1H, J3;4 9.55 Hz, H-3),
0
3.52 (t, 1H, J4;5 8.33 Hz, H-4), 3.49 (t, 1H, J5;6 4.76 Hz,
0
H-5), 3.69 (dd, 1H, J6;6 12.10 Hz, H-6), 3.86 (dd, 1H,